HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- ((2- bromophenyl)sulfonyl)- 5- methoxy- 3- ((4- methyl- 1- piperazinyl)methyl)- 1H- indole dimesylate monohydrate

5-HT6 receptor antagonist; structure in first source

Also Known As:

SUVN-502

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - 1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - 1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate: 2

Experts

1.	Nirogi, Ramakrishna: 2 articles (05/2018 - 10/2017)
2.	Bhyrapuneni, Gopinadh: 1 article (05/2018)
3.	Goyal, Vinod Kumar: 1 article (05/2018)
4.	Muddana, Nageswara Rao: 1 article (05/2018)
5.	Mudigonda, Koteshwara: 1 article (05/2018)
6.	Palacharla, Raghava Choudary: 1 article (05/2018)
7.	Pandey, Santosh Kumar: 1 article (05/2018)
8.	Ajjala, Devender Reddy: 1 article (10/2017)
9.	Aleti, Raghupathi: 1 article (10/2017)
10.	Boggavarapu, Rajesh Kumar: 1 article (10/2017)

Related Diseases

1.	Dementia (Dementias) 05/01/2018 - "SUVN-502, a selective 5-HT6 receptor antagonist, was found to be active in preclinical models of cognitive deterioration suggesting a potential role in the treatment of dementia related to Alzheimer's disease. " 10/25/2017 - "A sensitive and rapid LC-MS/MS method was developed and validated for the quantification of SUVN-502 and M1 of SUVN-502, a 5-HT6 receptor antagonist for the treatment of dementia associated with Alzheimer's disease. "
2.	Alzheimer Disease (Alzheimer's Disease) 05/01/2018 - "SUVN-502, a selective 5-HT6 receptor antagonist, was found to be active in preclinical models of cognitive deterioration suggesting a potential role in the treatment of dementia related to Alzheimer's disease. " 10/25/2017 - "A sensitive and rapid LC-MS/MS method was developed and validated for the quantification of SUVN-502 and M1 of SUVN-502, a 5-HT6 receptor antagonist for the treatment of dementia associated with Alzheimer's disease. "

Related Drugs and Biologics

1.	serotonin 6 receptor